That Cancer Conversation · 2026-02-05 · 39 min
Welcome back to That Cancer Conversation! Drugs like Mounjaro and Wegovy are helping millions of people across the UK lose weight faster and more effectively. That’s important for us, because obesity is one of the leading preventable causes of cancer. So, with obesity and cancer on the rise around the world, could weight loss drugs be a way for us to tackle them both together? To help break down the science of weight loss injections and how they work, we’re joined by Dr Rachel Orritt, one of our health information managers at Cancer Research UK. We also speak to Dr Matthew Harris, a surgeon and Cancer Research UK Clinical Research Fellow, about how he and his fellow researchers are working to answer the long list of questions we still have about weight loss drugs and cancer. - Discussed on today’s episode: Weight loss drugs and cancer: what we know so far PADRAIC project Causes of cancer and reducing your risk
Other episodes covering the same guests and topics, from across The B2B Podcast Index.
How Targeted Radiotherapy Is Changing Cancer Care w/ John Babich, President, CSO, Ratio TherapeuticsCareTalk: Healthcare. Unfiltered. · on cancer94 / 100
#192 - Slowing Things Down to Speed Up Research with Jared Forney of OktaAwkward Silences · on research90 / 100
Why your research needs a “thinking cave” with Sarah KlingThe Curiosity Current: A Market Research Podcast · on research89 / 100
The Safest of Them All: What If Safe Assets Aren't Safe? (ft. Vincent Mortier, Group CIO of Amundi and Deputy CEO of Amundi AM)2050 Investors · on research81 / 100
Rapid Response: OpenAI’s Critterz blowback - Director Nik Kleverov on year zero for HollywoodPioneers of AI · on science76 / 100
Building Self-Accelerating AI with MirendilAI + a16z · on research65 / 100
